GlassScriptPhysician profile
Julie Gardner
NPI 1396253241
$3,185.22
in general payments reported to CMS, 2019-2025
35 companies · $898 in 2025
The $898 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $615 · 2022: $726 · 2023: $386 · 2024: $559 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $522.17 | 2021-2025 | Gattex |
| Abbvie INC. | $494.03 | 2021-2025 | |
| Intuitive Surgical, INC. | $287.60 | 2022-2023 | Da Vinci Surgical System |
| Myriad Genetic Laboratories, INC. | $248.65 | 2021-2025 | Myrisk |
| Kerecis Limited | $215.13 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Ethicon US, LLC | $195.17 | 2021-2025 | Harmonic, Linx Reflux Management System |
| Medtronic, INC. | $157.46 | 2022-2025 | Progrip |
| Allergan, INC. | $137.40 | 2021 | |
| Si-Bone, INC. | $95.46 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $86.61 | 2024-2025 | |
| Integra Lifesciences Corporation | $74.91 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Polynovo North America LLC | $73.87 | 2022 | |
| Csl Behring | $71.99 | 2021 | |
| Solventum Corporation | $55.64 | 2024-2025 | Prevena |
| Hydrofera LLC | $53.28 | 2025 | Hydrofera Blue |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $40.30 | 2024-2025 | Affinity |
| Smith+Nephew, INC. | $37.50 | 2025 | Collagenase Santyl |
| Pacira Pharmaceuticals Incorporated | $31.05 | 2022-2025 | Exparel |
| Heron Therapeutics, INC. | $28.30 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $27.57 | 2024 | Lynparza, Keytruda |
| Conmed Corporation | $24.89 | 2024 | Airseal |
| Innocoll Pharmaceuticals Limited | $20.43 | 2022 | |
| Access Pro Medical, LLC | $19.97 | 2022 | |
| Innovation Technologies INC | $19.83 | 2025 | Irrisept |
| Teleflex LLC | $19.41 | 2024 | Titan Sgs |
| Baxter Healthcare | $19.06 | 2022 | |
| Davol INC. | $16.58 | 2021 | |
| Reprise Biomedical, INC. | $15.99 | 2025 | Miro3d |
| Hologic INC | $14.92 | 2022 | |
| Hologic Sales and Service, LLC | $14.35 | 2025 | Magtrace, Magseed, Trunode |
| Zimmer Biomet Holdings, INC. | $14.02 | 2024 | Ribfix Blu Advantage |
| Coopersurgical, INC. | $13.57 | 2025 | Onetrac Lx |
| Bard Peripheral Vascular, INC. | $13.52 | 2021 | |
| Kci USA, INC. | $12.84 | 2022 | |
| Boston Scientific Corporation | $11.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julie Gardner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.